Cell-specific CD39 expression in macrophages and CD73 expression in liver cancer cells synergistically activated the eATP-eAdo pathway and produced more adenosine, impacting CD8+T cell function and driving anti-PD-1 immunotherapy resistance. This evidence concerns the gene NT5E and liver cancer.